Latest news with #OneHealthGroup
BBC News
30-04-2025
- Health
- BBC News
Scunthorpe surgical hub proposed to cut waiting times
A surgical hub could be built in Scunthorpe to help ease waiting lists for elective provider One Health Group has proposed the facility for undeveloped scrubland off Normanby Road near the town's driving test single-storey building would include a reception and waiting area, consultation rooms, a physio room, recovery unit, and 12 en-suite bedrooms for patients. North Lincolnshire Council will decide whether to approve the hub which would focus on orthopaedics, spinal, general surgery and gynaecology. Sheffield-based One Health Group is an NHS-designated body, meaning it carries out treatments for the National Health Service. The group currently treats about 12,000 patients a year across its existing sites, according to the Local Democracy Reporting Service."The opportunity exists to provide an efficient use of this site providing employment for up to 20 staff," Hay Associates Ltd stated in a planning document on behalf of the applicant. It added the facility would "provide a much-needed medical facility which will relieve the pressure currently mounting on the NHS". Listen to highlights from Lincolnshire on BBC Sounds, watch the latest episode of Look North or tell us about a story you think we should be covering here.
Yahoo
10-04-2025
- Business
- Yahoo
Estimating The Intrinsic Value Of One Health Group Plc (LON:OHGR)
The projected fair value for One Health Group is UK£1.56 based on Dividend Discount Model One Health Group's UK£1.83 share price indicates it is trading at similar levels as its fair value estimate The average discount for One Health Group's competitors is currently 34% Does the April share price for One Health Group Plc (LON:OHGR) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by taking the expected future cash flows and discounting them to their present value. The Discounted Cash Flow (DCF) model is the tool we will apply to do this. Models like these may appear beyond the comprehension of a lay person, but they're fairly easy to follow. We would caution that there are many ways of valuing a company and, like the DCF, each technique has advantages and disadvantages in certain scenarios. For those who are keen learners of equity analysis, the Simply Wall St analysis model here may be something of interest to you. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. We have to calculate the value of One Health Group slightly differently to other stocks because it is a healthcare company. Instead of using free cash flows, which are hard to estimate and often not reported by analysts in this industry, dividends per share (DPS) payments are used. This often underestimates the value of a stock, but it can still be good as a comparison to competitors. We use the Gordon Growth Model, which assumes dividend will grow into perpetuity at a rate that can be sustained. The dividend is expected to grow at an annual growth rate equal to the 5-year average of the 10-year government bond yield of 2.3%. We then discount this figure to today's value at a cost of equity of 6.4%. Compared to the current share price of UK£1.8, the company appears around fair value at the time of writing. The assumptions in any calculation have a big impact on the valuation, so it is better to view this as a rough estimate, not precise down to the last cent. Value Per Share = Expected Dividend Per Share / (Discount Rate - Perpetual Growth Rate) = UK£0.06 / (6.4% – 2.3%) = UK£1.6 We would point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows. If you don't agree with these result, have a go at the calculation yourself and play with the assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at One Health Group as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 6.4%, which is based on a levered beta of 0.800. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. Check out our latest analysis for One Health Group Whilst important, the DCF calculation shouldn't be the only metric you look at when researching a company. The DCF model is not a perfect stock valuation tool. Preferably you'd apply different cases and assumptions and see how they would impact the company's valuation. For example, changes in the company's cost of equity or the risk free rate can significantly impact the valuation. For One Health Group, we've compiled three relevant elements you should explore: Risks: We feel that you should assess the 2 warning signs for One Health Group (1 is significant!) we've flagged before making an investment in the company. Future Earnings: How does OHGR's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart . Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered! PS. Simply Wall St updates its DCF calculation for every British stock every day, so if you want to find the intrinsic value of any other stock just search here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
